grant

CD39 protects against renal ischaemic-reperfusion injury [ 2007 - 2009 ]

Also known as: Understanding organ dysfunction

Research Grant

[Cite as http://purl.org/au-research/grants/nhmrc/447706]

Researchers: Prof Karen Dwyer (Principal investigator) ,  Prof Anthony D'Apice Prof Harshal Nandurkar Prof Peter Cowan

Brief description In many medical settings, such as heart attacks, strokes, transplantation, heart surgery, shock and infection, the blood supply to an organ may be compromised resulting in damage. The cessation of blood flow depletes the organ of oxygen and generates a number of toxic changes. Re-establishing blood flow to the organ is essential to prevent further damage, however the reestablishment of blood flow itself can be harmful to the organ. The return of blood flow, oxygen and energy can actually promote more widespread injury - a process known as ischaemia-reperfusion injury (IRI). A greater understanding of IRI should aid in the development of drugs that minimise its impact. The overall aim of this work is to examine the role of a molecule - CD39 - in IRI. This molecule is ideally situated to minimise injury - it is located on cells that line blood vessels and, as such, is able to directly neutralise toxins released in response to this injury. We, therefore, believe that it will be protective in this setting. We have developed animals that express this molecule and have preliminary results to suggest that these animals are protected in experimental models of IRI as well as in several other models including heart transplantation surgery; processes that share many features with IRI. Moreover, mice deplete of this molecule are prone to more severe IRI. We aim to investigate this by using animals both lacking and expressing CD39. Blood flow to the kidneys will be interrupted for 30 minutes and kidney function assessed at 24 and 48 hours. We will then delve into the potential mechanisms underpinning IRI by determining whether the kidney itself or the blood cells afford protection, which has direct clinical implications.

Funding Amount $AUD 441,584.64

Funding Scheme NHMRC Project Grants

Notes New Investigator Grant

Click to explore relationships graph
Identifiers
Viewed: [[ro.stat.viewed]]